# EDGAR Filing Document

**Accession Number:** 0001757064
**File Stem:** 0001757064-25-000019
**Filing Date:** 2025-11
**Character Count:** 2776
**Document Hash:** b377127832864641bcb706490d23fdc5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001757064-25-000019.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001757064-25-000019

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genfit S.A.
- **CENTRAL INDEX KEY:** 0001757064
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** I0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 333-271312
- **FILM NUMBER:** 251480880

**BUSINESS ADDRESS:**
- **STREET 1:** PARC EURASANTE
- **STREET 2:** 885, AVENUE EUGENE AVINEE
- **CITY:** LOOS
- **STATE:** I0
- **ZIP:** 59120
- **BUSINESS PHONE:** 33 3 20 16 4000

**MAIL ADDRESS:**
- **STREET 1:** PARC EURASANTE
- **STREET 2:** 885, AVENUE EUGENE AVINEE
- **CITY:** LOOS
- **STATE:** I0
- **ZIP:** 59120

<u>VIA EDGAR</u>

From:

GENFIT

Parc Eurasanté - 885 Avenue Eugène Avinée

59 120 Loos, France

To :

U.S Securities and Exchange Commission

Division of Corporation Finance

100 F. Street N.E.

Washington, D.C. 20549

November 14, 2025

Re: GENFIT S.A. – Request for Withdrawal of Registration Statement on Form F-3 (File No. 333-271312)

Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the "***Securities Act***"), GENFIT S.A. (the "***Company***") hereby requests that the Securities and Exchange Commission (the "***Commission***") consent to the withdrawal of the Company's registration statement on Form F-3 (File No. 333-271312), together with the exhibits thereto, which was filed on April 18, 2023 (the "***Registration Statement***"), as of the date hereof or at the earliest practicable date hereafter. The Registration Statement was declared effective by the Commission on May 4, 2023, but no securities have been issued or sold under the Registration Statement.

Accordingly, the Company respectfully requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company's account to be offset against the filing fee for any future registration statement or registration statements.

If you have questions regarding this request, please contact the Company's legal counsel, Stefanie Magner, at +33 3 20 16 40 76.

Very truly yours,

<u>/s/ Pascal PRIGENT</u> 

Name: Pascal PRIGENT

Title: Chief Executive Officer

cc:&nbsp;&nbsp;&nbsp;&nbsp;Stefanie MAGNER (Chief Compliance Officer, EVP International Legal Affairs, GENFIT S.A.)

&nbsp;&nbsp;&nbsp;&nbsp;

<br>